SU11248

What SU11248 Means in Everyday Medical Language

SU11248 is a drug used to treat certain types of cancer. It is also known by other names such as SU011248, sunitinib malate, and the brand name Sutent. This medicine belongs to a group called tyrosine kinase inhibitors and antiangiogenesis agents. It works by blocking proteins that help cancer cells grow and by preventing tumors from making new blood vessels they need to survive and grow.

Why SU11248 Can Matter in Cancer Care

SU11248 offers a treatment option for adults with specific cancers, including gastrointestinal stromal tumors (GIST), pancreatic neuroendocrine tumors, and renal cell carcinoma (a type of kidney cancer). It may be used when cancer is advanced or has returned after surgery, such as after a kidney removal (nephrectomy). By targeting cancer growth and blood supply, it can help control the disease. Researchers are also studying SU11248 for other cancers to see if it might help more patients in the future.

What Patients Might See or Hear About SU11248

Patients and caregivers might come across the term SU11248 in medical reports, treatment plans, or discussions with their healthcare team. It may also appear in information about clinical trials or drug guides. Because the drug has several names—SU011248, SU11248, sunitinib malate, and Sutent—it can be confusing. The key is to understand that these names refer to the same medicine. If you see this term, it’s a good idea to ask your care team how it relates to your treatment or condition.

Where the Term SU11248 Might Appear

You might find SU11248 mentioned in your medical records, especially in pathology reports, treatment plans, or notes from your doctor. It can also appear on clinical trial websites or drug information pages. Sometimes, it is listed under different names, so comparing the wording can help avoid confusion.

What SU11248 Does Not Automatically Mean

Seeing the term SU11248 does not mean you have a specific diagnosis or that this drug is definitely part of your treatment. It is simply the name of a medicine that may be used for certain cancers. The presence of this term in your records should prompt a conversation with your healthcare team to understand its role in your care.

Common Sources of Confusion and How to Avoid Them

Because SU11248 has several names, patients and caregivers might be unsure if they refer to different drugs or treatments. Remember that SU011248, SU11248, sunitinib malate, and Sutent all mean the same medicine. Always ask your care team to clarify what the term means in your specific case to avoid misunderstandings.

Questions to Ask Your Care Team

If you see SU11248 mentioned, consider asking: What is this drug, and how does it relate to my cancer? Is it part of my current or future treatment plan? What are the possible benefits and side effects? Are there clinical trials involving this drug that I might consider? Understanding these points can help you feel more informed and involved.

How to Read the Term in Context

It’s important to read SU11248 in the context of your medical records, test results, or treatment plans. The term alone does not provide a diagnosis or treatment decision. Always discuss with your healthcare team to understand what this drug means for your care.

Safety and Next Steps

This information is educational and does not decide what is safe or appropriate for any individual patient. If you see SU11248 in your medical records or hear it mentioned, the best next step is to ask your healthcare provider what it means for your specific situation. They can explain how it fits into your diagnosis, treatment options, or clinical trials.